Zydus Lifesciences consolidated net profit declines 41.47% in the March 2022 quarter

20 May 2022 , 02:44 PM

Net profit of Zydus Lifesciences declined 41.47% to Rs 397.40 crore in the quarter ended March 2022 as against Rs 679.00 crore during the previous quarter ended March 2021. Sales rose 4.49% to Rs 3741.80 crore in the quarter ended March 2022 as against Rs 3580.90 crore during the previous quarter ended March 2021. For the full year,net profit rose 110.32% to Rs 4487.30 crore in the year ended March 2022 as against Rs 2133.60 crore during the previous year ended March 2021. Sales rose 4.97% to Rs 14827.60 crore in the year ended March 2022 as against Rs 14125.00 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	3741.80	3580.90	4	14827.60	14125.00	5
OPM %	18.78	23.11	–	22.53	23.50	–
PBDT	743.30	774.00	-4	5684.10	3205.90	77
PBT	557.90	598.70	-7	4971.10	2536.30	96
NP	397.40	679.00	-41	4487.30	2133.60	110

Powered by Capital Market – Live News